## [Patients and caregivers](/patients-and-caregivers "Patients and caregivers") Patients and caregivers know better than anyone what it is like to live with a serious disease. We listen. And we learn from people’s experiences. We work together to create medicines that address the needs of people living with disease and achieve the results that matter to them. ## The Novartis commitment to patients and caregivers We recognize the importance of patients and caregivers understanding what they can expect from Novartis. [Learn more](/patients-and-caregivers/novartis-commitment-patients-and-caregivers "Learn more") ## Our work with patients and caregivers is built on four commitments ### 1. Respecting and understanding the patient community perspective ### 2. Expanding access to our medicines ### 3. Conducting responsible clinical trials ### 4. Recognizing the importance of transparency and reporting Read more about our commitment to patients and caregivers [here](/sites/novartis_com/files/novartis-commitment-patients-caregivers-factsheet.pdf "novartis-commitment-patients-caregivers-factsheet.pdf"). 40+ Patient organizations represented [Download the 2025 factsheet (PDF 1.2 MB)](/sites/novartis_com/files/novartis-commitment-patients-caregivers-factsheet.pdf "Download the 2025 factsheet (PDF 1.2 MB)") 77k+ Novartis associates own it as an aspiration* ![doctor and nurse](/sites/novartis_com/files/styles/cta_image/public/doctor-and-nurse.jpg.webp?itok=PUJBC8Ub "doctor and nurse") ## Disclosure of patient organization funding Novartis annually discloses monetary and non-monetary support to patient organizations around the globe by June 30. [Learn more](/investors/reporting-and-transparency-hub/patient-organization-funding "Learn more") ## Our commitment – reporting 2025 progress ### 94% #### early research programs in general medicines were developed with patient perspective and insights before first-in-human trials (healthy volunteers). ### 7 194 #### new patients were reached through managed access programs with 94% of requests approved for 37 compounds in 62 countries. MAPs provide access to locally unauthorized Novartis medicines. ### 81 #### clinical development projects consulted people living with a disease on the design and/or conduct of clinical trials. ### 191 #### Clinical trials with patient reported outcomes (PRO) were conducted in 81 countries. ### 402 #### Simplified summaries from Phase I-IV clinical trials were sent to investigators to share with over 71 000 trial participants and posted on [novartis.com/clinicaltrials](/clinicaltrials). ### 30 m #### Patients reached through access approaches. ## Clinical Trials [ ![healthcare professionals clinical trials in progressclinical trials](/sites/novartis_com/files/styles/cards_50_50/public/healthcare-professionals-clinical-trials-in-progressclinical-trials.jpg.webp?itok=bbeUWHLO "healthcare professionals clinical trials in progressclinical trials") ### About clinical trials Clinical trials are scientific studies conducted to find better ways to prevent, screen for, diagnose or treat disease. ](/clinicaltrials/about-clinical-trials) [ ![A doctor speaks with a patient](/sites/novartis_com/files/styles/cards_50_50/public/patients-caregivers-participating.jpg.webp?itok=P0-tF-4r "Doctor and patient") ### Participating in Novartis clinical trials Novartis is currently conducting clinical trials around the world for a number of diseases. ](/clinicaltrials/patients) [ ![patients caregivers managed access](/sites/novartis_com/files/styles/cards_50_50/public/patients-caregivers-managed-access.jpg.webp?itok=fbOQz2RL "patients caregivers managed access") ### Managed access programs Novartis managed access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases. Your physician may request access. ](/healthcare-professionals/managed-access-programs) [ ![Portrait of a patient and a healthcare professional](/sites/novartis_com/files/styles/cards_50_50/public/patient-and-hcp-portrait.jpg.webp?itok=V1wAucDB "Portrait of a patient and a healthcare professional") ### Diversity Diversity in clinical trials helps us improve the quality of care for every patient, while also helping to address health inequities in society. We are working to improve both the diversity of patients enrolled in our clinical research and the investigators involved in our trials. ](https://www.novartis.com/sites/novartis_com/files/commitment-for-diversity-in-clinical-trials.pdf) --- ### Collaborations with patient organizations ![Japanese doctor and patients discussing illness](/sites/novartis_com/files/styles/cta_image/public/2024-02/japanese-doctor-patients-discussing-illness.jpg.webp?itok=z8fHPKfn "Japanese doctor and patients discussing illness") ## Listening to the CML patient community Improving the patient experience and removing potential barriers to clinical trial participation [Read more](/stories/listening-cml-patient-community "Read more") ![Doctor with senior woman in an office](/sites/novartis_com/files/styles/cta_image/public/2022-12/doctor-with-senior-woman-patient-in-office.jpg.webp?itok=puIUDfXw "Doctor with senior woman in an office") ## Patient organizations and Novartis Working together with patient organizations and healthcare organizations helps us create better medicines. This collaboration is based on values of mutual respect, trust and transparency. [Learn more](/investors/reporting-and-transparency-hub/patient-organization-funding "Learn more") --- ![men handshake_0](/sites/novartis_com/files/styles/cta_image/public/men-handshake_0.jpg.webp?itok=WsLmJHCR "men handshake_0") ## External funding Novartis may provide funding to **legitimate organizations** to support its mission to discover new ways to improve and extend people's lives, advance scientific and medical knowledge, and supporting the communities where Novartis associates live and work. [Learn more](/healthcare-professionals/novartis-external-funding "Learn more") ![mother daughter hug](/sites/novartis_com/files/styles/cta_image/public/mother-daughter-hug.jpg.webp?itok=cYLYbUTz "mother daughter hug") ## Patient perspectives Patients and caregivers know better than anyone what it is like to live with a serious disease. Visit our YouTube channel to watch our patient stories to learn more about insights from the patient community. [Watch the videos](https://www.youtube.com/playlist?list=PL0BDA1BC68D92CB94 "Watch the videos") For questions about Novartis, medical inquiries about our products and/or information about services, we recommend you contact the Novartis office in your country. If you’re seeking a global list of products, visit our Global Product Portfolio. [Country contacts](/about/locations "Country contacts") [Novartis directory](/novartis-directory "Novartis directory") [Global product portfolio](/about/products "Global product portfolio") [Report side effects](/report "Report side effects") \*Based on 2025 data.